Biological ActivityAmylin (AMY3) antagonist (IC50 = 0.3 μM). Protects neuronal cells from Aβ(1-42)-induced cytotoxicity in vitro. Brain penetrant. Improves spatial memory and reduces Aβ plaque number and total area in a mouse Alzheimer's disease model.
(Modifications: Cys-26 = C-terminal amide, Disulfide bridge between 1 - 26)
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Cyclic AC253, a novel amylin receptor antagonist, improves cognitive deficits in a mouse model of Alzheimer's disease.
Soudy et al.
Alzheimers Dement. (N Y), 2016;3:44
Amylin in Alzheimer's disease: Pathological peptide or potential treatment?
No product specific FAQs exist for this product, however you mayView all Peptide FAQs
Reviews for cAC 253
There are currently no reviews for this product. Be the first to review cAC 253 and earn rewards!
Have you used cAC 253?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image